Welcome to our dedicated page for Scotts Miracle Gr SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Scotts Miracle-Gro Company filings document the formal record for a North American branded consumer lawn and garden company. Recent 8-K disclosures furnish operating results and financial condition, revised historical financial information reflecting Hawthorne as a discontinued operation, and the completed sale of The Hawthorne Gardening Company.
The filing record also covers capital structure and governance matters, including a senior secured credit agreement, shareholder approval of an amended and restated Long-Term Incentive Plan, forms of restricted stock unit, performance unit and stock option awards, and definitive proxy disclosures on annual meeting proposals and executive compensation.
Aviles Edith reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Edith Aviles received a grant of 105 dividend equivalent rights tied to existing equity awards. These derivative rights were awarded at a price of $0.00 per right and increase her directly held derivative position to 552 rights.
The dividend equivalent rights accrue on deferred or restricted stock units and become exercisable proportionately with those underlying units. Each right is described as economically equivalent to one common share of Scotts Miracle-Gro, giving the holder the same cash value as regular share dividends when paid.
Scotts Miracle-Gro president and COO Nathan Eric Baxter reported an administrative change in his holdings of the company’s common shares. The Form 4 lists an “other transaction” involving 90.025 common shares at $55.54 per share, after which his directly held stake is shown as 66,722.4238 common shares.
The filing also updates indirect ownership information. It notes 36,993 common shares held through Hagedorn Partnership, L.P., a Delaware limited partnership where Baxter is a general partner. Under securities rules, he may be deemed a beneficial owner of a proportionate interest in those partnership-held shares.
Kingdon Mark D reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director Mark D. Kingdon reported an award of 105 Dividend Equivalent Rights on common shares. These rights accrued on DSU or RSU grants at a price of $0.0000 per right, bringing his directly held Dividend Equivalent Rights to 552 following the transaction.
Each Dividend Equivalent Right is the economic equivalent of one common share and becomes exercisable proportionately with the related DSUs or RSUs.
Scotts Miracle-Gro Co director and major shareholder Katherine Littlefield Hagedorn reported an award of derivative securities tied to the company’s common stock. On the reported date, she acquired 33 dividend equivalent rights at a price of $0.00 per right, bringing her holdings of these rights to 33.
According to the disclosure, these dividend equivalent rights accrue on deferred or restricted stock unit grants and become exercisable in step with the underlying DSUs or RSUs. Each right is described as being economically equivalent to one common share of Scotts Miracle-Gro.
Scotts Miracle-Gro director Roberto Candelino reported an equity-related award. On March 6, 2026, he acquired 68 dividend equivalent rights at a price of $0.0000 per right, bringing his holdings in these instruments to 218 rights.
The footnote explains that these dividend equivalent rights accrue on DSU or RSU grants and become exercisable in step with the underlying DSUs or RSUs. Each right is described as the economic equivalent of one common share of Scotts Miracle-Gro, aligning the director’s compensation with shareholder outcomes.
Scotts Miracle-Gro executive Christopher Hagedorn reported a small change in his common share holdings. On February 27, 2026, a Form 4 lists an “other” type transaction involving 3.907 common shares at $55.54 per share. Following this adjustment, his directly owned stake stands at 57,531.3734 common shares.
SCOTTS MIRACLE-GRO CO Chairman & CEO James Hagedorn reported new equity-related activity. On March 6, 2026 he acquired 2,396.642 phantom stock units at $0 per unit, increasing his phantom stock balance to 237,393.148 units.
Each phantom stock unit represents the right to receive one common share of Scotts Miracle-Gro or its cash value and is payable in cash after his employment ends. He also reported indirect holdings of 31,533.640 common shares through a 401(k) plan and a proportionate interest in 997,910 common shares held by Hagedorn Partnership, L.P. A separate J-code transaction on February 27, 2026 involved 36.010 directly held common shares at $55.54 per share, leaving him with 87,471.9828 directly held common shares.
Scotts Miracle-Gro director Adam Hanft reported an equity-based compensation award. On March 6, 2026, he acquired 105 Dividend Equivalent Rights at a price of $0.00 per right as a grant or award. Following this transaction, he holds 552 Dividend Equivalent Rights directly. According to the disclosure, these rights accrue on DSU or RSU grants and become exercisable proportionately with those units, and each right is the economic equivalent of one common share of Scotts Miracle-Gro.
Johnson Stephen L reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Stephen L. Johnson received a grant of 138 Dividend Equivalent Rights on March 6, 2026. These rights were awarded at a price of $0.00 per right as a form of derivative-based compensation.
The dividend equivalent rights accrue on DSU or RSU grants and become exercisable proportionately with the DSUs or RSUs they relate to. Each right is the economic equivalent of one common share of Scotts Miracle-Gro. Following this award, Johnson directly holds a total of 750 Dividend Equivalent Rights.
Sandoval Brian E reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director Brian E. Sandoval received an equity-related award. On the reported date, he was granted 151 dividend equivalent rights tied to existing deferred or restricted stock unit grants, at a stated price of $0 per right. Following this award, he holds 787 dividend equivalent rights, each economically equivalent to one common share.